Curis Inc (CRIS)
11.17
-0.03
(-0.27%)
USD |
NASDAQ |
May 28, 16:00
11.31
+0.14
(+1.25%)
After-Hours: 20:00
Curis Cash from Operations (Quarterly): -13.23M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -13.23M |
December 31, 2023 | -10.19M |
September 30, 2023 | -8.181M |
June 30, 2023 | -7.868M |
March 31, 2023 | -12.20M |
December 31, 2022 | -12.27M |
September 30, 2022 | -13.12M |
June 30, 2022 | -12.13M |
March 31, 2022 | -16.82M |
December 31, 2021 | -8.171M |
September 30, 2021 | -9.61M |
June 30, 2021 | -6.659M |
March 31, 2021 | -13.18M |
December 31, 2020 | -5.715M |
September 30, 2020 | -5.877M |
June 30, 2020 | -5.131M |
March 31, 2020 | -9.016M |
December 31, 2019 | -5.599M |
September 30, 2019 | -6.704M |
June 30, 2019 | -6.669M |
March 31, 2019 | -7.233M |
December 31, 2018 | -4.94M |
September 30, 2018 | -8.223M |
June 30, 2018 | -6.938M |
March 31, 2018 | -9.964M |
Date | Value |
---|---|
December 31, 2017 | -7.505M |
September 30, 2017 | -16.48M |
June 30, 2017 | -9.223M |
March 31, 2017 | -15.15M |
December 31, 2016 | -9.387M |
September 30, 2016 | -7.583M |
June 30, 2016 | -10.85M |
March 31, 2016 | -7.987M |
December 31, 2015 | -10.86M |
September 30, 2015 | -4.483M |
June 30, 2015 | -6.786M |
March 31, 2015 | -7.759M |
December 31, 2014 | -4.692M |
September 30, 2014 | -2.085M |
June 30, 2014 | -4.730M |
March 31, 2014 | -5.306M |
December 31, 2013 | -5.513M |
September 30, 2013 | 0.2774M |
June 30, 2013 | 0.0238M |
March 31, 2013 | -4.328M |
December 31, 2012 | -13.34M |
September 30, 2012 | -4.181M |
June 30, 2012 | -1.612M |
March 31, 2012 | 3.938M |
December 31, 2011 | 8.688M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-16.82M
Minimum
Mar 2022
-5.131M
Maximum
Jun 2020
-9.417M
Average
-8.598M
Median
Cash from Operations (Quarterly) Benchmarks
AIM ImmunoTech Inc | -4.815M |
Perspective Therapeutics Inc | 13.85M |
Protalix BioTherapeutics Inc | 4.188M |
Electromed Inc | 1.351M |
Armata Pharmaceuticals Inc | -10.58M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | 18.91M |
Cash from Financing (Quarterly) | -2.406M |
Free Cash Flow | -39.47M |
Free Cash Flow Per Share (Quarterly) | -2.288 |
Free Cash Flow to Equity (Quarterly) | -13.23M |
Free Cash Flow Yield | -63.11% |